Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

June 1, 2025; Volume 66,Issue 6

Editor’s Page

  • You have access
    Funding Reductions Threaten the Future of Medical Innovation
    Johannes Czernin, Carolyn J. Anderson, Ramsey Derek Badawi, Henryk Barthel, Frank M. Bengel, Thomas Beyer, Irene Buvat, Jérémie Calais, Sharmila Dorbala, Alexander E. Drzezga, Ken Herrmann, Thomas A. Hope, Hossein Jadvar, David A. Mankoff, Heinrich R. Schelbert and Wolfgang A. Weber
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 829; DOI: https://doi.org/10.2967/jnumed.125.270157

Discussions with Leaders

  • You have access
    Stakeholders of Theranostics
    Richard Zimmermann and Thomas Beyer
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 830-832; DOI: https://doi.org/10.2967/jnumed.125.270085

The State of the Art

  • You have access
    The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
    Vishnu Murthy, Vinicius Ludwig, Andrei Gafita, Thomas A. Hope and Jeremie Calais
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 833-838; DOI: https://doi.org/10.2967/jnumed.124.268818

Continuing Education

  • You have access
    Approaches to Imaging Immune Activation Using PET
    Ashwin Singh Parihar, Niharika Pant, Pedram Heidari, Lawrence Fong and Amir Iravani
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 839-847; DOI: https://doi.org/10.2967/jnumed.124.268289

Hot Topics

  • You have access
    Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?
    Rodney J. Hicks
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 848-850; DOI: https://doi.org/10.2967/jnumed.125.269496

Focus on Molecular Imaging

  • You have access
    From Genome to Phenome: Opportunities and Challenges of Molecular Imaging
    Mei Tian, Leroy Hood, Arturo Chiti, Markus Schwaiger, Satoshi Minoshima, Yasuyoshi Watanabe, Keon Wook Kang and Hong Zhang
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 851-855; DOI: https://doi.org/10.2967/jnumed.124.267660

Highlights

  • You have access
    2024 SNMMI Highlights Lecture: Cardiovascular Sciences
    James T. Thackeray
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 856-861; DOI: https://doi.org/10.2967/jnumed.125.269988

Editorial

  • You have access
    FDA Approval of 18F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion Imaging?
    Thomas H. Schindler, Timothy M. Bateman, Daniel S. Berman, Panithaya Chareonthaitawee, Lorraine E. De Blanche, Vasken Dilsizian, Sharmila Dorbala, Robert J. Gropler, Leslee L. Shaw, Prem Soman, David E. Winchester, Hein J. Verberne, Sukhjeet Ahuja, Rob Beanlands, Marcelo Di Carli, Venkatesh L. Murthy, Terrence D. Ruddy and Ronald G. Schwartz
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 862-864; DOI: https://doi.org/10.2967/jnumed.124.269154

Oncology

  • Clinical

    • FEATURED ARTICLE OF THE MONTH

      • CD70-Targeted [<sup>18</sup>F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
        You have access
        CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
        Binyu Shi, You Zhang, Shuo Wu, Dongsheng Xu, Qianyun Wu, Wenzhi Jia, Shuxian An, Cheng Wang, Yongrui Bai, Jianjun Liu, Junjun Zhou and Weijun Wei
        Journal of Nuclear Medicine June 1, 2025, 66 (6) 865-872; DOI: https://doi.org/10.2967/jnumed.125.269585
    • Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
      You have access
      Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
      Randy Yeh, Fresia Pareja, Parnian Shobeiri, Dara Ross, Vetri S. Jayaprakasam, Ali Aria Razmaria, Joshua Z. Drago, Audrey Mauguen, Serge K. Lyashchenko, Brian M. Zeglis, Jason S. Lewis and Gary A. Ulaner
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 873-879; DOI: https://doi.org/10.2967/jnumed.124.269227
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer
        You have access
        Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer
        Justin S. Hachey, Tara D. Viray, Mattia Matasci, Domenico Ravazza, Dario Neri and Jason S. Lewis
        Journal of Nuclear Medicine June 1, 2025, 66 (6) 880-885; DOI: https://doi.org/10.2967/jnumed.124.268859

Theranostics and Radiopharmaceutical Therapies

  • Clinical

    • Determination of the Intralesional Distribution of Theranostic <sup>124</sup>I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
      You have access
      Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
      Alexandre França Velo, Alexandra Giantini Larsen, John L. Humm, Pat Zanzonico, Sofia Haque, Mark Souweidane and Neeta Pandit-Taskar
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 886-891; DOI: https://doi.org/10.2967/jnumed.124.267995
    • BRIEF COMMUNICATION

      • Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT
        You have access
        Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT
        Mateus de Oliveira Taveira, Ali Aria Razmaria, Heiko Schoder and Randy Yeh
        Journal of Nuclear Medicine June 1, 2025, 66 (6) 892-895; DOI: https://doi.org/10.2967/jnumed.124.269361
    • BRIEF COMMUNICATION

      • First-in-Human Serum Stability Studies of [<sup>177</sup>Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy
        Open Access
        First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy
        Veronika Felber, Nadine Holzleitner, Markus Joksch, Tim Suhrbier, Gunhild von Amsberg, Sarah Schwarzenböck, Jens Kurth, Martin Heuschkel, Thomas Günther and Bernd J. Krause
        Journal of Nuclear Medicine June 1, 2025, 66 (6) 896-899; DOI: https://doi.org/10.2967/jnumed.124.269132
    • Multicycle Dosimetric Behavior and Dose–Effect Relationships in [<sup>177</sup>Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
      You have access
      Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
      Gunjan Kayal, Molly E. Roseland, Chang Wang, Kellen Fitzpatrick, David Mirando, Krithika Suresh, Ka Kit Wong and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 900-908; DOI: https://doi.org/10.2967/jnumed.124.269389
  • Basic

    • <sup>161</sup>Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas
      Open Access
      161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas
      Elisa Rioja-Blanco, Yara Banz, Christoph Schlapbach, Urban Novak, Tanja Chiorazzo, Nicole L. Bertschi, Peter Bernhardt, Pascal V. Grundler, Nicholas P. van der Meulen, Michal Grzmil, Roger Schibli and Martin Behe
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 909-915; DOI: https://doi.org/10.2967/jnumed.124.268805
    • <sup>212</sup>Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
      You have access
      212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
      Satyendra Kumar Singh, Nathan Kauffman, Isabelle Maria Lynch, Zeynep Meral Kunt, Kurt R. Zinn, Dalen Agnew and Jinda Fan
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 916-921; DOI: https://doi.org/10.2967/jnumed.124.269190

Endocrinology

  • Clinical

    • BRIEF COMMUNICATION

      • Initial Experience with Dual-Time-Point [<sup>18</sup>F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism
        You have access
        Initial Experience with Dual-Time-Point [18F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism
        Thorsten Derlin, Dennis Kleine-Döpke, Lavinia Neubert, Tobias L. Ross, Bastian P. Ringe, Moritz Schmelzle and Frank M. Bengel
        Journal of Nuclear Medicine June 1, 2025, 66 (6) 922-925; DOI: https://doi.org/10.2967/jnumed.124.269387

Neurology

  • Clinical

    • [<sup>18</sup>F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies
      Open Access
      [18F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies
      Joachim Brumberg, Nils Schröter, Ganna Blazhenets, M. Aymen Omrane, Christian Volz, Cornelius Weiller, Michel Rijntjes, Lars Frings, Sabine Hellwig, Wolfgang H. Jost and Philipp T. Meyer
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 926-931; DOI: https://doi.org/10.2967/jnumed.124.268956
    • First-in-Human Study of <sup>18</sup>F-Labeled PET Tracer for Glutamate AMPA Receptor [<sup>18</sup>F]K-40: A Derivative of [<sup>11</sup>C]K-2
      Open Access
      First-in-Human Study of 18F-Labeled PET Tracer for Glutamate AMPA Receptor [18F]K-40: A Derivative of [11C]K-2
      Sadamitsu Ichijo, Tetsu Arisawa, Mai Hatano, Waki Nakajima, Tomoyuki Miyazaki, Tsuyoshi Eiro, Yuuki Takada, Ryunosuke Iai, Akane Sano, Masaki Sonoda, Yutaro Takayama, Yuichi Kimura and Takuya Takahashi
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 932-939; DOI: https://doi.org/10.2967/jnumed.124.269405
  • Basic

    • In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [<sup>11</sup>C]HSP990 in Healthy Aging and Neurodegeneration
      Open Access
      In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
      Romy Cools, Koen Vermeulen, Eline Vonck, Veerle Baekelandt, Cassis Varlow, Valeria Narykina, Christopher Cawthorne, Koen Van Laere, Wim Vanduffel, Neil Vasdev and Guy Bormans
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 940-947; DOI: https://doi.org/10.2967/jnumed.124.268961

AI/Advanced Image Analysis

  • Clinical

    • An External, Independent Validation of an <em>O</em>-(2-[<sup>18</sup>F]Fluoroethyl)-<span class="sc">l</span>-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
      You have access
      An External, Independent Validation of an O-(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
      Nathaniel Barry, Jake Kendrick, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Roslyn J. Francis, Nicholas Bucknell, Eng-Siew Koh, Andrew M. Scott, Martin A. Ebert, Robin Gutsche, Keith George Ciantar, Norbert Galldiks, Karl-Josef Langen and Philipp Lohmann
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 948-953; DOI: https://doi.org/10.2967/jnumed.124.268925

Physics and Instrumentation

  • Clinical

    • Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
      You have access
      Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
      Ian Alberts, Stuart More, Karen Knapp, Riccardo Mei, Stefano Fanti, Clemens Mingels, Lorenzo Nardo, Nii Boye Hammond, Harish Nagaraj, Axel Rominger, Gary J.R. Cook and Don Wilson
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 954-960; DOI: https://doi.org/10.2967/jnumed.124.269203
    • Feasibility of Ultra-Low-Activity <sup>18</sup>F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
      You have access
      Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
      Charlotte L.C. Smith, Gerben J. C. Zwezerijnen, Marijke E. den Hollander, Josée M. Zijlstra, C. Willemien Menke-van der Houven van Oordt, Idris Bahce, Maqsood Yaqub and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 961-966; DOI: https://doi.org/10.2967/jnumed.124.269272
    • BRIEF COMMUNICATION

      • Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX–Based Attenuation Correction Using a Long–Axial-Field-of-View PET/CT Scanner
        You have access
        Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX–Based Attenuation Correction Using a Long–Axial-Field-of-View PET/CT Scanner
        Hasan Sari, Mohammadreza Teimoorisichani, Marco Viscione, Clemens Mingels, Robert Seifert, Kuangyu Shi, Michael Morris, Eliot Siegel, Babak Saboury, Thomas Pyka and Axel Rominger
        Journal of Nuclear Medicine June 1, 2025, 66 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.124.268380
  • Translational

    • Quantitative Total-Body Imaging of Blood Flow with High-Temporal-Resolution Early Dynamic <sup>18</sup>F-FDG PET Kinetic Modeling
      Open Access
      Quantitative Total-Body Imaging of Blood Flow with High-Temporal-Resolution Early Dynamic 18F-FDG PET Kinetic Modeling
      Kevin J. Chung, Abhijit J. Chaudhari, Lorenzo Nardo, Terry Jones, Moon S. Chen, Ramsey D. Badawi, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine June 1, 2025, 66 (6) 973-980; DOI: https://doi.org/10.2967/jnumed.124.268706

The Illustrated Post

  • You have access
    Safety and Efficacy of 20 Cycles of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    Kerry E. Jewell, James P. Buteau, Elizabeth Medhurst, Edmond M. Kwan, Shahneen Sandhu, Arun A. Azad and Michael S. Hofman
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 981-982; DOI: https://doi.org/10.2967/jnumed.124.269447

Letters to the Editor

  • You have access
    Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
    Emmanuel Deshayes, Ioannis Karfis, Lore Santoro, Magdalena Mileva, Rachele Danieli, Kévin Hebert, Marco Maccauro, Carlo Chiesa and Manuel Bardiès
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 983; DOI: https://doi.org/10.2967/jnumed.124.268880
  • You have access
    [68Ga]Ga-RAYZ-8009: A Peptide PET Tracer for Targeting HCC in Humans
    Yue Zhang, Jiangtao Yue, Xuhong Yang, Guanghai Fei, Yicheng Ni and Yue Li
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 984; DOI: https://doi.org/10.2967/jnumed.124.269294
  • You have access
    The Randomized, Phase 2 Trial LuCAP Study
    Murat Tuncel, Gürsan Kaya, Oğuz Kodaz, Cem Türkan and Meltem Çağlar Tuncalı
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 984-985; DOI: https://doi.org/10.2967/jnumed.125.269549
  • You have access
    Reply to “The Randomized, Phase 2 LuCAP Study”
    Swayamjeet Satapathy and Ashwani Sood
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 986; DOI: https://doi.org/10.2967/jnumed.125.270026
  • You have access
    FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals
    Marianna Dakanali, Steven S. Zigler, Sally W. Schwarz, Michael L. Nickels, Reiko Oyama, Henry F. VanBrocklin and Peter J. H. Scott
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 986-988; DOI: https://doi.org/10.2967/jnumed.125.269885
  • You have access
    Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
    Michael D.F. Goldenberg, Taranjit S. Gill and Jitesh Dhingra
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 988; DOI: https://doi.org/10.2967/jnumed.125.269865
Back to top
Previous

In this issue

Journal of Nuclear Medicine: 66 (6)
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
  • Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer
Sign up for alerts

Jump to

  • Editor’s Page
  • Discussions with Leaders
  • The State of the Art
  • Continuing Education
  • Hot Topics
  • Focus on Molecular Imaging
  • Highlights
  • Editorial
  • Oncology
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Theranostics and Radiopharmaceutical Therapies
    • Clinical
      • BRIEF COMMUNICATION
      • BRIEF COMMUNICATION
    • Basic
  • Endocrinology
    • Clinical
      • BRIEF COMMUNICATION
  • Neurology
    • Clinical
    • Basic
  • AI/Advanced Image Analysis
    • Clinical
  • Physics and Instrumentation
    • Clinical
      • BRIEF COMMUNICATION
    • Translational
  • The Illustrated Post
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
  • Total-Body Perfusion Imaging with [11C]-Butanol
More...
SNMMI

© 2025 SNMMI

Powered by HighWire